Clinical Laserthermia Systems
3.68
SEK
+1.1 %
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
1 following
+1.1%
-4.66%
-32%
-39.36%
-86.16%
-88.35%
-98.32%
-98.83%
-98.51%
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Read moreMarket cap
74.21M SEK
Turnover
263.14K SEK
Revenue
8.27M
EBIT %
-797.22 %
P/E
-
Dividend yield-%
-
Financial calendar
21/2
2025
Annual report '24
16/5
2025
Interim report Q1'25
15/8
2025
Interim report Q2'25
ShowingAll content types
CLS: The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024.
CLS genomför riktad nyemission av aktier till garanter i samband med genomförd Optionsinlösen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools